Company intelligence / Profile preview

Intressa Vascular

Isnes, Namur, Belgiumintressavascular.com ↗

Ownership: Private
Development stage: Clinical

Overview

The Allay® Aortic Stent uses proprietary multilayer braiding technology to treat Type B aortic dissections by recentralizing blood flow inside the true lumen while preserving branch perfusion. It aims to provide next-generation endovascular treatment with low risk of complications. Published clinical data referenced includes Costache et al., J Endovasc Ther. 2021;28(1):20–31

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Allay Aortic Stent

Clinical

Indications: Aortic dissection

Beyond the preview

Go deeper on Intressa Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intressa Vascular.

Explore the full profile